Glaxosmithkline Plc (GSK) SEC Filing 6-K Foreign Issuer report for the period ending Tuesday, October 1, 2019

Glaxosmithkline Plc

CIK: 1131399 Ticker: GSK

View differences made from one to another to evaluate Glaxosmithkline Plc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 6-K Foreign Issuer Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Glaxosmithkline Plc.


Assess how Glaxosmithkline Plc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Glaxosmithkline Plc's Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


Ticker: GSK
CIK: 1131399
Form Type: 6-K Foreign Issuer Report
Accession Number: 0001654954-19-011300
Submitted to the SEC: Tue Oct 01 2019 11:38:06 AM EST
Accepted by the SEC: Tue Oct 01 2019
Period: Tuesday, October 1, 2019
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: